BCLI
RhumbLine Advisers’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-28,235
| Closed | -$108K | – | 2996 |
|
|
2021
Q1 | $108K | Hold |
28,235
| – | – | ﹤0.01% | 2927 |
|
|
2020
Q4 | $128K | Buy |
28,235
+1,970
| +8% | +$8.91K | ﹤0.01% | 2937 |
|
|
2020
Q3 | $444K | Sell |
26,265
-2,640
| -9% | -$44.6K | ﹤0.01% | 2340 |
|
|
2020
Q2 | $324K | Buy |
+28,905
| New | +$324K | ﹤0.01% | 2540 |
|